Directorate Change

Flomerics Group PLC 04 September 2006 Flomerics Group PLC ("Flomerics" or the "Company") Appointment of Director Subsequent to the announcement made by the Company on 15 June 2006, regarding the proposed acquisition of Nika GmbH (Nika) and the Extraordinary General Meeting held on 5 July 2006, the board is pleased to announce the appointment of Wolfgang Biedermann, aged 44, as a director of the Company. Wolfgang Biedermann is CEO of Pricap Venture Partners AG ("Pricap), which prior to the acquisition by Flomerics, was the largest shareholder in Nika. Pricap is a venture capital company and has a portfolio of investments with a net equity value of approximately €35 million. He studied in Paris, Oxford and Berlin at the EAP, the European School of Management and achieved a BA and achieved an MBA with distinction from the Harvard Business School. Wolfgang Biedermann's continuing directorships over the past five years are as follows: Steganos GmbH, Frankfurt GAM GmbH, Hamburg Lampito Vermogensverwaltungsgesellschaft mbH, Hamburg MaWoBi Beteiligungs GmbH, Hamburg Pricap Venture Partners AG, Hamburg NEWMEX Holding GmbH, Hamburg Smart Fuel Cell AG, Munich PACT XPP Technologies AG, Munich thinXXS Microtechnology AG, Zweibrucken UMS United Medical Systems International AG, Hamburg In addition, in his capacity as a venture capital investor, Mr. Biedermann was a non-executive director of the privately held early stage company Extr@com AG, Munich, when it went into receivership in December 2003 and of the privately held early stage company Scorpion Technologies AG, Hamburg, when it went into receivership in April 2006. Gary Carter, Chief Executive, commented: "I am delighted that Wolfgang, who has a wealth of business experience, especially in the technology arena will be joining our board and assisting us in our growth plans." Wolfgang Biedermann commented: "I am convinced that by acquiring NIKA, Flomerics has set the grounds to emerge as a real powerhouse in the fast growing CFD/EFD industry." There are no other matters to be disclosed in relation to Schedule 2, paragraph G of the AIM rules. For further information please contact: Flomerics Group PLC 020 8487 3000 Gary Carter Chief Executive Chris Ogle Finance Director Conduit PR 020 7429 6666 Laurence Read / Angus Prentice 07979 955 923 This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings